Since the first study demonstrated that IL-23 and not the structurally similar IL-12 is the central cytokine contributing to the pathogenesis of autoimmune diseases (4, 5), the importance of IL-23 in neuroinflammation has been further deciphered in many preclinical and clinical studies. This evidence concerns the gene IL37 and autoimmune disease.